849213-22-5

Basic information

• Product Name: C₅₃H₈₃NO₁₄Si₂
• Synonyms: C₅₃H₈₃NO₁₄Si₂
• CAS NO: 849213-22-5
• Molecular Weight: 1014.41
• Mol File: 849213-22-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: C₅₃H₈₃NO₁₄Si₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₅₃H₈₃NO₁₄Si₂(849213-22-5)
• EPA Substance Registry System: C₅₃H₈₃NO₁₄Si₂(849213-22-5)

Safety Data

• Hazardous Substances Data: 849213-22-5(Hazardous Substances Data)

Upstream product

• 849213-27-0 C₂₀H₃₀FNO₅ 
• 849213-18-9 sidechain 
• 849213-20-3 C₄₁H₅₇NO₁₄ 
• 994-30-9 triethylsilyl chloride 
• 32981-86-5 10-deacetylbaccatin III 
• 194864-02-3 C-7,C-10-dibenzyloxycarbonyl-10-deacetyl baccatin III 
• 849213-21-4 C₅₃H₈₅NO₁₄Si₂ 

Downstream Products

• 849213-23-6 C₅₃H₈₇NO₁₄Si₂ 
• 849213-15-6 TPI₂₈₇ 
• 849213-14-5 C₄₃H₆₁NO₁₅ 
• 849213-24-7 C₅₅H₈₉NO₁₅Si₂ 
• 1051405-83-4 C₄₃H₆₁NO₁₅ 
• 849213-17-8 C₄₆H₆₃NO₁₅ 
• 849213-25-8 9-α-hydroxy-10-α-acetyl-2'(R,S)-hydroxy-3'(S)-isobutyl-3'-(N-t-butoxycarbonyl)-taxane 
• 849213-26-9 TPI 287 
• 942950-93-8 C₄₆H₆₃NO₁₅ 

Relevant articles and documents

BIOLOGICALLY ACTIVE TAXANE ANALOGS AND METHODS OF TREATMENT BY ORAL ADMINISTRATION

The present invention relates to a novel chemical compound of formula S-(I) for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents.

Biologically Active Taxane Analogs and Methods of Treatment

The present application relates to new taxane analogs, pharmaceutical compositions comprising such analogs and methods of treating cancer comprising such compositions. The compounds according to the present application have the general formula: wherein R